Clinical Trials Directory

Trials / Completed

CompletedNCT00874068

The Effects of Dietary Palmitic Acid Triacylglyceride Position on Bone Strength Parameters in Infants

The Effects of Dietary Palmitic Acid Triacylglyceride Position on Anthropometric Measures, Bone Strength Parameters, Stool Characteristics and Stool Biochemistry in Preterm and Term Infants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
94 (actual)
Sponsor
Enzymotec · Industry
Sex
All
Age
1 Month
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the effect of high sn-2 palmitic acid based infant formula on bone strength parameters.

Detailed description

InFatTM is an advanced basic-fat ingredient, which mimics the fat composition and properties of human milk fat and enabling optimal intake of the essential calcium and energy (in the form of fatty acids) and easy digestion. These benefits are the results of a unique fatty acid composition on the glycerol backbone, which ensure high level of palmitic acid at the middle (sn-2) position. The purpose of this study is to determine the effect of high sn-2 palmitic acid based infant formula on bone strength parameters, anthropometric parameters, wellbeing and stool characteristics in term and preterm infants.

Conditions

Interventions

TypeNameDescription
OTHERInFat™ based infant formulahigh sn-2 palmitic acid oil based infant formula
OTHERStandard vegetable oil based infant formulastandard vegetable oil based infant formula

Timeline

Start date
2009-02-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2009-04-02
Last updated
2011-02-24

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00874068. Inclusion in this directory is not an endorsement.